© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Insulet Corp. (PODD) stock surged +1.34%, trading at $141.17 on NASDAQ, up from the previous close of $139.30. The stock opened at $139.00, fluctuating between $136.46 and $142.22 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 07, 2026 | 138.00 | 142.22 | 136.46 | 141.17 | 1.59M |
| Aug 06, 2026 | 130.90 | 139.48 | 130.11 | 139.30 | 3.25M |
| Aug 05, 2026 | 128.00 | 138.41 | 126.40 | 133.26 | 7.15M |
| Aug 04, 2026 | 166.34 | 170.99 | 164.31 | 166.82 | 1.75M |
| Aug 03, 2026 | 168.56 | 172.11 | 166.66 | 169.70 | 1.41M |
| Jul 31, 2026 | 164.57 | 168.36 | 162.43 | 165.35 | 1.31M |
| Jul 30, 2026 | 165.68 | 168.38 | 161.62 | 165.68 | 1.21M |
| Jul 29, 2026 | 166.52 | 171.78 | 165.25 | 170.62 | 1.13M |
| Jul 28, 2026 | 167.22 | 172.92 | 166.69 | 167.47 | 1.3M |
| Jul 27, 2026 | 165.62 | 168.77 | 164.00 | 165.00 | 1.12M |
| Jul 24, 2026 | 159.21 | 164.33 | 158.31 | 163.26 | 1.15M |
| Jul 23, 2026 | 159.47 | 160.29 | 157.56 | 158.38 | 1.14M |
| Jul 22, 2026 | 165.70 | 165.70 | 157.44 | 158.93 | 1.37M |
| Jul 21, 2026 | 163.28 | 165.79 | 162.62 | 163.72 | 1.14M |
| Jul 20, 2026 | 164.13 | 168.25 | 161.90 | 167.37 | 1.65M |
| Jul 17, 2026 | 162.25 | 165.54 | 159.01 | 164.06 | 1.4M |
| Jul 16, 2026 | 161.14 | 169.85 | 161.14 | 164.43 | 1.5M |
| Jul 15, 2026 | 158.38 | 163.78 | 156.78 | 159.28 | 1.33M |
| Jul 14, 2026 | 158.80 | 160.10 | 153.84 | 159.12 | 1.94M |
| Jul 13, 2026 | 161.48 | 164.45 | 161.23 | 162.06 | 1.62M |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
| Employees | 5400 |
| Beta | 1.11 |
| Sales or Revenue | $1.70B |
| 5Y Sales Change% | 1.54% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |